{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-176473","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.114441+00:00","generated_at":"2026-06-25T00:56:42.656965+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Pliant shareholders re-elect directors, approve say-on-pay at 2022 annual meeting","bullets":["Shareholders elected John Curnutte (22.7M for) and Smital Shah (22.7M for) as Class II directors.","Advisory vote on named executive officer compensation passed with 27.9M for, 111.6K against.","Advisory vote on frequency of future say-on-pay approved with 28.0M favoring one-year interval.","Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 34.1M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-176473","json":"https://secwatch.observer/filing/0001193125-22-176473.json","markdown":"https://secwatch.observer/filing/0001193125-22-176473.md","text":"https://secwatch.observer/filing/0001193125-22-176473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/0001193125-22-176473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000119312522176473/d370205d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:56:42.656965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}